Health
Russia completes clinical trials of second potential COVID-19 vaccine
Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency cited ...Russia to supply 25 million COVID-19 vaccine doses to Nepal
Russia’s sovereign wealth fund said on Tuesday it had agreed to supply 25 million doses of its potential COVID-19 vaccine to Nepal ...Moderna COVID-19 vaccine appears safe, shows signs of working in older adults
Results from an early safety study of Moderna Inc’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at ...Global coronavirus death toll tops 1 million
The worldwide death toll from the coronavirus eclipsed 1 million on Tuesday, nine months into a crisis that has devastated the global ...Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial
A single dose of Johnson & Johnson’s <JNJ.N> experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an ...Russia agrees to supply 35 million doses of COVID-19 vaccine to Uzbekistan
Russia’s sovereign wealth fund said on Friday it had agreed to supply up to 35 million doses of the Russian experimental vaccine ...AstraZeneca still waiting for FDA go-ahead to resume U.S. trial
AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine ...Johnson & Johnson begins Phase 3 Covid-19 vaccine trial in U.S.
Johnson & Johnson said Wednesday it was entering the final Phase 3 stage of its Covid-19 vaccine clinical trial following positive results ...Russia to register second COVID-19 vaccine by Oct. 15
Russia expects to register a second potential vaccine against COVID-19 by Oct. 15, the TASS news agency cited Russian consumer safety watchdog ...Moderna sees 20 million doses of COVID-19 vaccine candidate by year end
Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end ...














